Wikipedia -WSS

Wikipedia

author：fashion 2025-10-01 07:41:39 - browse：4864

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Childhood vaccination ad campaign launches in the U.K.

explore

WSS

5 ways to address the shortage of health care workers

There’s a way to spot data fakery. All journals should be using it

How a Boston hospital is priming medical residents to use GPT

CDC advisory group OKs chikungunya vaccine

CDC panel: People 65 and older should get a Covid spring booster shot

5 ways to address the shortage of health care workers

focus

Wikipedia

focus

As demand for Covid shots wanes, Moderna seeks its next success

A new ‘biological computer' targets cancer while sparing healthy cells

Hepatitis C has a cure — but many Americans still lack access to it

'CMA Fest' 2023: How to watch, who is performing and more

How to save PrEP access — and even expand it

When a patient nears the end, a feared therapy can comfort

After affirmative action ruling, medical educators look to 'holistic review'

How a Boston hospital is priming medical residents to use GPT

Virginia high school admissions case could be legal follow

The stock market has soared this year, but will it last? Experts weigh in

focus

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Study fuels hope CAR

Study fuels hope CAR

Caribou posts encouraging results on off

STAT Madness 2024: Meet the contenders

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

hotspot

explore

leisure time

leisure time